PMID- 34216238 OWN - NLM STAT- MEDLINE DCOM- 20211027 LR - 20211116 IS - 1435-1463 (Electronic) IS - 0300-9564 (Print) IS - 0300-9564 (Linking) VI - 128 IP - 8 DP - 2021 Aug TI - The language profile in multiple system atrophy: an exploratory study. PG - 1195-1203 LID - 10.1007/s00702-021-02372-6 [doi] AB - BACKGROUND: The evidence about the language performance profile of multiple system atrophy (MSA) is limited, but its definition may lead to a more comprehensive characterization of the disorder and contribute to clarify the involvement of the basal ganglia in language abilities. OBJECTIVE: The objectives of the study were: (1) to evaluate the reliability of the Screening for Aphasia in NeuroDegeneration (SAND) in MSA patients; (2) compare the linguistic profiles among MSA and Parkinson's disease (PD) patients and healthy controls (HC), and (3) assess relationships between language impairment and cognitive status and MSA motor subtypes. METHODS AND RESULTS: Forty patients with a diagnosis of MSA, 22 HC and 17 patients with PD were enrolled in the present study. By excluding the writing task that showed a poor acceptability, we showed that the MSA-tailored SAND Global Score is an acceptable, consistent and reliable tool to screen language disturbances in MSA. MSA patients performed worse than HC, but not than PD, in MSA-tailored SAND Global Score, repetition, reading and semantic association tasks. We did not find significant differences between MSA phenotypes. MSA patients with mild cognitive impairment-multiple domain presented worse language performances as compared to MSA patients with normal cognition and mild cognitive impairment-single domain. CONCLUSION: The MSA-tailored SAND Global Score is a consistent and reliable tool to screen language disturbances in MSA. Language disturbances characterize MSA patients irrespective of disease phenotype, and parallel the decline of global cognitive functions. CI - (c) 2021. The Author(s). FAU - Cuoco, Sofia AU - Cuoco S AD - Neuroscience Section, Department of Medicine, Surgery and Dentistry, Center for Neurodegenerative Diseases (CEMAND), University of Salerno, 84131, Salerno, Italy. FAU - Picillo, Marina AU - Picillo M AD - Neuroscience Section, Department of Medicine, Surgery and Dentistry, Center for Neurodegenerative Diseases (CEMAND), University of Salerno, 84131, Salerno, Italy. FAU - Carotenuto, Immacolata AU - Carotenuto I AD - Neuroscience Section, Department of Medicine, Surgery and Dentistry, Center for Neurodegenerative Diseases (CEMAND), University of Salerno, 84131, Salerno, Italy. FAU - Erro, Roberto AU - Erro R AD - Neuroscience Section, Department of Medicine, Surgery and Dentistry, Center for Neurodegenerative Diseases (CEMAND), University of Salerno, 84131, Salerno, Italy. FAU - Catricala, Eleonora AU - Catricala E AD - University School for Advanced Studies IUSS Pavia, Pavia, Italy. FAU - Cappa, Stefano AU - Cappa S AD - University School for Advanced Studies IUSS Pavia, Pavia, Italy. AD - IRCCS Fondazione Mondino, Pavia, Italy. FAU - Pellecchia, Maria Teresa AU - Pellecchia MT AUID- ORCID: 0000-0002-6217-313X AD - Neuroscience Section, Department of Medicine, Surgery and Dentistry, Center for Neurodegenerative Diseases (CEMAND), University of Salerno, 84131, Salerno, Italy. mpellecchia@unisa.it. FAU - Barone, Paolo AU - Barone P AD - Neuroscience Section, Department of Medicine, Surgery and Dentistry, Center for Neurodegenerative Diseases (CEMAND), University of Salerno, 84131, Salerno, Italy. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20210703 PL - Austria TA - J Neural Transm (Vienna) JT - Journal of neural transmission (Vienna, Austria : 1996) JID - 9702341 SB - IM MH - Cognition MH - *Cognitive Dysfunction/diagnosis/etiology MH - Humans MH - *Multiple System Atrophy/complications/diagnosis MH - *Parkinson Disease/complications/diagnosis MH - Reproducibility of Results PMC - PMC8322009 OTO - NOTNLM OT - Cognition OT - Language OT - Mild cognitive impairment OT - Multiple System Atrophy EDAT- 2021/07/04 06:00 MHDA- 2021/10/28 06:00 PMCR- 2021/07/03 CRDT- 2021/07/03 12:07 PHST- 2021/03/29 00:00 [received] PHST- 2021/06/20 00:00 [accepted] PHST- 2021/07/04 06:00 [pubmed] PHST- 2021/10/28 06:00 [medline] PHST- 2021/07/03 12:07 [entrez] PHST- 2021/07/03 00:00 [pmc-release] AID - 10.1007/s00702-021-02372-6 [pii] AID - 2372 [pii] AID - 10.1007/s00702-021-02372-6 [doi] PST - ppublish SO - J Neural Transm (Vienna). 2021 Aug;128(8):1195-1203. doi: 10.1007/s00702-021-02372-6. Epub 2021 Jul 3.